Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. ALS patients suffer from a progressive loss of motor neurons, leading to respiratory failure within 3 to 5 years after diagnosis. Available therapies only slow down the disease progression moderately or extend the lifesp...

Descripción completa

Detalles Bibliográficos
Autores principales: Klingl, Yvonne E., Pakravan, Donya, Van Den Bosch, Ludo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Recent Advances in Als Pathogenesis and Therapeutics ‐ Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327724/
https://www.ncbi.nlm.nih.gov/pubmed/32726472
http://dx.doi.org/10.1111/bph.15217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327724/
https://www.ncbi.nlm.nih.gov/pubmed/32726472
http://dx.doi.org/10.1111/bph.15217

Ejemplares similares